T2* “Susceptibility Vessel Sign” Demonstrates Clot Location and Length in Acute Ischemic Stroke
Open Access
- 11 October 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (10) , e76727
Abstract
The aim of our study was to evaluate, in acute ischemic stroke patients, the diagnostic accuracy of the MRI susceptibility vessel sign (SVS) against catheter angiography (DSA) for the detection of the clot and its value in predicting clot location and length. We identified consecutive patients (2006–2012) admitted to our center, where 1.5 T MRI is systematically implemented as first-line diagnostic work-up, with: (1) pre-treatment 6-mm-thick multislice 2D T2* sequence; (2) delay from MRI-to-DSA 94%. Inter- and intra-observer ICC was excellent for clot length as measured on T2* (ĸ ≥0.97) and as measured on DSA (ĸ ≥0.94). Correlation between T2* and DSA for clot length was excellent (ICC: 0.88, 95%CI: 0.81–0.92; Bland & Altman: mean bias of 1.6% [95%CI: -4.7 to 7.8%], Passing & Bablok: 0.91). SVS is a specific marker of clot location in the anterior and posterior circulation. Clot length greater than 6 mm can be reliably measured on T2*.Keywords
This publication has 40 references indexed in Scilit:
- Comparison of Susceptibility Weighted Imaging and TOF-Angiography for the Detection of Thrombi in Acute StrokePLOS ONE, 2013
- Cerebral Microbleeds: Burden Assessment by Using Quantitative Susceptibility MappingRadiology, 2012
- CT and MRI Early Vessel Signs Reflect Clot Composition in Acute StrokeStroke, 2011
- Venous Hemodynamics May Enhance Collateral Perfusion and the Fibrinolytic Milieu in Paradoxical EmbolismStroke, 2009
- Thrombus Burden Is Associated With Clinical Outcome After Intra-Arterial Therapy for Acute Ischemic StrokeStroke, 2008
- MR Imaging Detection of Cerebral Microbleeds: Effect of Susceptibility-Weighted Imaging, Section Thickness, and Field StrengthAmerican Journal of Neuroradiology, 2008
- Imaging the ClotStroke, 2005
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- A New Biometrical Procedure for Testing the Equality of Measurements from Two Different Analytical Methods. Application of linear regression procedures for method comparison studies in Clinical Chemistry, Part IClinical Chemistry and Laboratory Medicine (CCLM), 1983